Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Overnight normal-release morphine scheduling in cancer pain
ISRCTN90932532Phase 3Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Sep 2001
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of morphine in cancer pain (2 arms), sponsored by United States Department of Health and Human Services. Started Sep 2001; status: completed.
02
Drugs
morphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ISRCTN90932532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN90932532.